PTGS2 and cancer: A growing amount of data also suggest that the cancer-protective effect of COXIBs is both due to their COX-2 inhibiting potential as well as the ability to interfere with the Wnt/β-catenin pathway, independently of COX-2/PGE2 pathway [28].